26 Sep CREATE Medicines
Posted at 15:30h
in
Daniel Getts, CEO
Oct. 6 | 9:30am | FLW Ballroom G
Cambridge, MA
(Private)
CREATE Medicines is a clinical-stage biotechnology company pioneering in vivo immune programming. The company’s proprietary mRNA-LNP platform directly engineers T cells, NK cells, and myeloid cells inside the body to enable scalable, repeat-dose, off-the-shelf immunotherapies. CREATE is advancing a pipeline of in vivo CAR therapies across autoimmune diseases and cancer.